Medicine & Life Sciences
Urinary Bladder Neoplasms
100%
Strontium-89
83%
Zoledronic Acid
62%
Prostatic Neoplasms
60%
Survival
39%
Randomized Controlled Trials
38%
Docetaxel
36%
Recurrence
33%
Biomarkers
32%
Castration
31%
Drug Therapy
29%
Prospective Studies
27%
Renal Cell Carcinoma
27%
Therapeutics
26%
Cost-Benefit Analysis
26%
Epithelial Cell Adhesion Molecule
26%
Cohort Studies
25%
Breast Neoplasms
25%
Sunitinib
24%
Bone and Bones
23%
Carcinoma, Intraductal, Noninfiltrating
22%
Tamoxifen
20%
Progression-Free Survival
18%
Muscles
17%
Clinical Trials
17%
Quality-Adjusted Life Years
16%
Hepatocellular Carcinoma
15%
Brentuximab Vedotin
15%
cabazitaxel
14%
abiraterone
14%
pazopanib
14%
Severe Acute Respiratory Syndrome
12%
Progesterone Receptors
11%
Coronavirus
11%
Cetuximab
11%
Neoplasm Metastasis
11%
Medical Overuse
11%
National Cancer Institute (U.S.)
10%
Frailty
10%
Confidence Intervals
10%
Selenium
10%
alpha-Fetoproteins
10%
Radioisotopes
10%
Preliminary Data
10%
Costs and Cost Analysis
10%
Androgen Receptors
10%
Chemoradiotherapy
10%
Immune System Diseases
10%
Vitamin E
9%
Hodgkin Disease
9%